BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10778970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis*

  1998cited by this paper
• bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.

  1998cited by this paper
• Characterization of the ETO and AML1–ETO proteins involved in the 8;21 translocation in acute myelogenous leukemia

  1998cited by this paper
• High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.

  1998cited by this paper
• Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia.

  1998cited by this paper
• Reversible Phosphorylation of Bcl2 following Interleukin 3 or Bryostatin 1 Is Mediated by Direct Interaction with Protein Phosphatase 2A*

  1998cited by this paper
• 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.

  1997cited by this paper
• Bcl-2 Phosphorylation Required for Anti-apoptosis Function*

  1997cited by this paper
• High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

  1997cited by this paper
• Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

  1997cited by this paper
• Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia.

  1997cited by this paper
• Caspases: the executioners of apoptosis.

  1997cited by this paper
• Mechanisms of apoptotic cell death

  1997cited by this paper
• The proto-oncogene Bcl-2 and its role in regulating apoptosis

  1997cited by this paper
• Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.

  1996cited by this paper
• UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line.

  1996cited by this paper
• Molecular thanatopsis: a discourse on the BCL2 family and cell death.

  1996cited by this paper
• bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.

  1995cited by this paper
• Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

  1994cited by this paper
• The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemia

  1994cited by this paper
• Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis.

  1994cited by this paper
• Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein.

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.

  1993cited by this paper
• Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia.

  1989cited by this paper
• Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia.

  1987cited by this paper

• Precision medicine in AML: overcoming resistance

  2024cites this paper
• The influence of BCL2, BAX, and ABCB1 gene expression on prognosis of adult de novo acute myeloid leukemia with normal karyotype patients

  2023cites this paper
• Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential

  2022cites this paper
• Proteomic Characterization of Spontaneous Stress-Induced In Vitro Apoptosis of Human Acute Myeloid Leukemia Cells; Focus on Patient Heterogeneity and Endoplasmic Reticulum Stress

  2021cites this paper
• Protein kinase C alpha-mediated phosphorylation of PIM-1L promotes the survival and proliferation of acute myeloid leukemia cells.

  2018cites this paper
• Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic

  2018cites this paper
• Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines

  2017cites this paper
• Quantitative assessment of BAX transcript and flow cytometric expression in acute myeloid leukemia: A prospective study

  2014cites this paper
• The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts

  2014cites this paper
• Roles of protein kinase C in cell death and breast cancer

  2013cites this paper
• An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies

  2013cites this paper
• BAX/BCL2 RMFI ratio predicts better induction response in pediatric patients with acute myeloid leukemia

  2013cites this paper
• Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.

  2012cites this paper
• Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells

  2012cites this paper
• Comparative proteomics in acute myeloid leukemia

  2012cites this paper
• Nuevas estrategias terapéuticas en leucemias agudas mieloblásticas: evaluación preclínica de la eficacia y el mecanismo de ación

  2011cites this paper
• MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex

  2011cites this paper
• The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias

  2011cites this paper
• Functional proteomic profiling of AML predicts response and survival.

  2009cites this paper
• Cell death in hematological tumors

  2009cites this paper
• Mitochondria-dependent apoptosis in yeast.

  2008cites this paper
• Novel Chimeric Peptide Inhibits Protein Kinase C and Induces Apoptosis in Human Immune Cells

  2008cites this paper
• Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.

  2008cites this paper
• Heat shock proteins and Bcl-2 expression and function in relation to the differential hyperthermic sensitivity between leukemic and normal hematopoietic cells

  2007cites this paper
• Novel Therapies Targeting the Apoptosis Pathway for the Treatment of Acute Myeloid Leukemia

  2007cites this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cites this paper
• Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML.

  2006cites this paper
• Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.

  2006cites this paper
• The Role of Protein Kinase C-Alpha in Hematologic Malignancies

  2006cites this paper
• Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

  2006cites this paper
• Specific modulation of apoptosis and Bcl-xL phosphorylation in yeast by distinct mammalian protein kinase C isoforms

  2006cites this paper
• Chemosensitizing multiple drug resistance of human carcinoma by bicyclol involves attenuated P-glycoprotein, GST-P and Bcl-2

  2006cites this paper
• Studying The Right Cell In Acute Myelogenous Leukemia: Dynamic Changes Of Apoptosis And Signal Transduction Pathway Protein Expression In Chemotherapy Resistant Ex-Vivo Selected “Survivor Cells”

  2006cites this paper
• Apoptosis and immaturity in acute myeloid leukemia

  2005cites this paper
• Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia

  2005cites this paper
• Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate.

  2004cites this paper
• Expression of Inducible Bcl-XS in Myeloid Leukemia: Compensatory Upregulation of Bcl-XL and Bcl-2 Prevents Apoptosis and Chemosensitization

  2004cites this paper
• The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.

  2004cites this paper
• Inhibition of Rat Mammary Gland Carcinogenesis by Simultaneous Targeting of Cyclooxygenase-2 and Peroxisome Proliferator-activated Receptor γ

  2004cites this paper
• Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia.

  2004cites this paper
• Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.

  2004cites this paper
• Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.

  2003cites this paper
• Apoptosis in hematological disorders.

  2003cites this paper
• Protein kinase C zeta nuclear translocation mediates the occurrence of radioresistance in friend erythroleukemia cells.

  2003cites this paper
• Biologic Therapy of Leukemia

  2003cites this paper
• Mechanisms of environmental chemical-induced apoptosis in dopaminergic cells: critical roles of protein kinase C-delta and relevance to Parkinson's disease

  2003cites this paper
• Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.

  2003cites this paper
• Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

  2003cites this paper
• Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells

  2003cites this paper
• High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)

  2002cites this paper
• An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.

  2002cites this paper
• Survival of B Lineage Leukemic Cells: Signals from the Bone Marrow Microenvironment

  2002cites this paper
• Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

  2002cites this paper
• Bcl-2 Family Members As Prognostic Indicators in AML

  2002cites this paper
• Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.

  2002cites this paper
• Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.

  2001cites this paper
• Phosphorylation of Bcl2 and regulation of apoptosis

  2001cites this paper
• Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view.

  2001cites this paper
• The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.

  2001cites this paper
• Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.

  2000cites this paper